rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2001-3-21
|
pubmed:abstractText |
The Intergroup Melanoma Surgical Trial began in 1983 to examine the optimal surgical margins of excision for primary melanomas of intermediate thickness (i.e., 1-4 mm). There is now a median 10-year follow-up.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1068-9265
|
pubmed:author |
pubmed-author:BalchC MCM,
pubmed-author:BarnhillR LRL,
pubmed-author:DesmondRR,
pubmed-author:Investigators from the Intergroup Melanoma Surgical Trial,
pubmed-author:JewellW RWR,
pubmed-author:KarakousisC PCP,
pubmed-author:MihmM CMC,
pubmed-author:RossM IMI,
pubmed-author:SmithTT,
pubmed-author:SoongS JSJ,
pubmed-author:TempleW JWJ,
pubmed-author:UristM MMM,
pubmed-author:WaneboH JHJ
|
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
101-8
|
pubmed:dateRevised |
2007-7-18
|
pubmed:meshHeading |
pubmed-meshheading:11258773-Humans,
pubmed-meshheading:11258773-Lymph Node Excision,
pubmed-meshheading:11258773-Melanoma,
pubmed-meshheading:11258773-Multivariate Analysis,
pubmed-meshheading:11258773-Neoplasm, Residual,
pubmed-meshheading:11258773-Neoplasm Invasiveness,
pubmed-meshheading:11258773-Neoplasm Recurrence, Local,
pubmed-meshheading:11258773-Neoplasm Staging,
pubmed-meshheading:11258773-Prospective Studies,
pubmed-meshheading:11258773-Regression Analysis,
pubmed-meshheading:11258773-Skin Neoplasms,
pubmed-meshheading:11258773-Survival Rate,
pubmed-meshheading:11258773-Time Factors,
pubmed-meshheading:11258773-Treatment Outcome
|
pubmed:year |
2001
|
pubmed:articleTitle |
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas.
|
pubmed:affiliation |
Johns Hopkins Medical Center, Baltimore, Maryland, USA. balchc@asco.org
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|